model: gpt-4-1106-preview
prompt: Write a paragraph of text in the style of a biomedical research article. Include the following protein complex name: eukaryotic translation initiation factor 4F. Use this name exactly as provided, avoiding any synonyms, aliases, abbreviated or expanded forms. Also avoid including any other names referring to a gene, protein, protein complex, protein part or component, or any other molecular entity containing amino acid residues. The text can include mentions of other biomedical entity types, such as chemical, organism, and disease names.
output: The intricate process of eukaryotic cellular translation initiation has been a focal point for understanding the regulation of protein synthesis, especially under various stress conditions and in the pathogenesis of diseases such as cancer. A key participant in this process is the eukaryotic translation initiation factor 4F (eIF4F), a multimeric protein complex essential for the recruitment of ribosomes to the messenger RNA cap structure. Recent studies have elucidated that the activity of eIF4F is modulated not just by association with cap structures but also through upstream signaling pathways involving kinases and phosphatases, which respond to cellular energy levels and stress signals. Pharmacological interventions aiming at disrupting the eIF4F-complex activity demonstrated a profound impact on the global protein synthesis rates, which in turn affect cell growth and survival. These findings have potential therapeutic implications, as targeting eIF4F activity may provide a novel approach for the treatment of malignancies that are characterized by dysregulated protein synthesis. The employment of small molecule inhibitors designed to selectively impede eIF4F function has emerged as a promising strategy in preclinical cancer models. Further research into the biological pathways regulating eIF4F and its interactions with other cellular components is imperative to fully harness its potential in therapeutic applications.
